The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease. - Hunter NB; Parsons HA; Cope L; Canzoniero JV; Navarro FCP; El-Refai S; Anampa JD; Sparano JA; Rimawi M; Storniolo AM; Mainor C; Nanda R; et al. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2026)